Neuronal transplant cells (Layton)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNeuronal transplant cells (Layton)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Neuronal cell therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLayton Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLayton Bioscience Inc
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A